Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 17 genes, 30 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Acute myeloid leukemia
|
Sirolimus Sirolimus 💬Acute myeloid leukemia
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Adipocytokine signaling pathway 💬 16 genes, 31 drugs (DrugBank) and 95 diseases |
MTOR [1] MTOR 💬Adipocytokine signaling pathway
|
Sirolimus Sirolimus 💬Adipocytokine signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬2. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Adipocytokine signaling pathway 💬 16 genes, 31 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬Adipocytokine signaling pathway
|
Infliximab Infliximab 💬Adipocytokine signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬3. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Adrenergic signaling in cardiomyocytes 💬 27 genes, 80 drugs (DrugBank) and 71 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | African trypanosomiasis 💬 9 genes, 22 drugs (DrugBank) and 59 diseases |
TNF [1] TNF 💬African trypanosomiasis
|
Infliximab Infliximab 💬African trypanosomiasis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬5. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases |
AGTR1 [1] AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬6. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases |
TNF [1] TNF 💬AGE-RAGE signaling pathway in diabetic complications
|
Infliximab Infliximab 💬AGE-RAGE signaling pathway in diabetic complications
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬7. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Alcoholic liver disease 💬 39 genes, 46 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Alcoholic liver disease
|
Infliximab Infliximab 💬Alcoholic liver disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬8. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Aldosterone synthesis and secretion 💬 20 genes, 38 drugs (DrugBank) and 62 diseases |
AGTR1 [1] AGTR1 💬Aldosterone synthesis and secretion
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬9. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
IL5 [1] IL5 💬Allograft rejection
|
Mepolizumab Mepolizumab 💬Allograft rejection
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬10. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
IL5 [1] IL5 💬Allograft rejection
|
Reslizumab Reslizumab 💬Allograft rejection
| Reslizumab | 044 [2] 44, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
TNF [1] TNF 💬Allograft rejection
|
Infliximab Infliximab 💬Allograft rejection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬12. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Alzheimer disease 💬 55 genes, 116 drugs (DrugBank) and 122 diseases |
MTOR [1] MTOR 💬Alzheimer disease
|
Sirolimus Sirolimus 💬Alzheimer disease
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬13. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Alzheimer disease 💬 55 genes, 116 drugs (DrugBank) and 122 diseases |
TNF [1] TNF 💬Alzheimer disease
|
Infliximab Infliximab 💬Alzheimer disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬14. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Amoebiasis 💬 19 genes, 29 drugs (DrugBank) and 63 diseases |
TNF [1] TNF 💬Amoebiasis
|
Infliximab Infliximab 💬Amoebiasis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬15. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | AMPK signaling pathway 💬 16 genes, 49 drugs (DrugBank) and 93 diseases |
MTOR [1] MTOR 💬AMPK signaling pathway
|
Sirolimus Sirolimus 💬AMPK signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Amyotrophic lateral sclerosis 💬 35 genes, 48 drugs (DrugBank) and 108 diseases |
MTOR [1] MTOR 💬Amyotrophic lateral sclerosis
|
Sirolimus Sirolimus 💬Amyotrophic lateral sclerosis
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬17. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Amyotrophic lateral sclerosis 💬 35 genes, 48 drugs (DrugBank) and 108 diseases |
TNF [1] TNF 💬Amyotrophic lateral sclerosis
|
Infliximab Infliximab 💬Amyotrophic lateral sclerosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬18. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Antifolate resistance 💬 8 genes, 21 drugs (DrugBank) and 66 diseases |
TNF [1] TNF 💬Antifolate resistance
|
Infliximab Infliximab 💬Antifolate resistance
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬19. Antifolate resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Antigen processing and presentation 💬 4 genes, 15 drugs (DrugBank) and 52 diseases |
TNF [1] TNF 💬Antigen processing and presentation
|
Infliximab Infliximab 💬Antigen processing and presentation
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬20. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Apelin signaling pathway 💬 12 genes, 30 drugs (DrugBank) and 72 diseases |
AGTR1 [1] AGTR1 💬Apelin signaling pathway
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬21. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | Apelin signaling pathway 💬 12 genes, 30 drugs (DrugBank) and 72 diseases |
MTOR [1] MTOR 💬Apelin signaling pathway
|
Sirolimus Sirolimus 💬Apelin signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬22. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | Apoptosis 💬 16 genes, 28 drugs (DrugBank) and 59 diseases |
TNF [1] TNF 💬Apoptosis
|
Infliximab Infliximab 💬Apoptosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬23. Apoptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
FCER1A [1] FCER1A 💬Asthma
|
Omalizumab Omalizumab 💬Asthma
| Omalizumab | 046 [7] 46, 53, 65, 98, 162, 226, 299 💬24. Asthma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL5 [1] IL5 💬Asthma
|
Mepolizumab Mepolizumab 💬Asthma
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬25. Asthma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL5 [1] IL5 💬Asthma
|
Reslizumab Reslizumab 💬Asthma
| Reslizumab | 044 [2] 44, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
TNF [1] TNF 💬Asthma
|
Infliximab Infliximab 💬Asthma
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬27. Asthma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases |
IL5 [1] IL5 💬Autoimmune thyroid disease
|
Mepolizumab Mepolizumab 💬Autoimmune thyroid disease
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬28. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases |
IL5 [1] IL5 💬Autoimmune thyroid disease
|
Reslizumab Reslizumab 💬Autoimmune thyroid disease
| Reslizumab | 044 [2] 44, 98 💬29. Autoimmune thyroid disease |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Autophagy - animal 💬 13 genes, 18 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Autophagy - animal
|
Sirolimus Sirolimus 💬Autophagy - animal
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬30. Autophagy - animal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Autophagy - other 💬 1 gene, 3 drugs (DrugBank) and 41 diseases |
MTOR [1] MTOR 💬Autophagy - other
|
Sirolimus Sirolimus 💬Autophagy - other
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬31. Autophagy - other
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Breast cancer 💬 21 genes, 60 drugs (DrugBank) and 74 diseases |
MTOR [1] MTOR 💬Breast cancer
|
Sirolimus Sirolimus 💬Breast cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬32. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | C-type lectin receptor signaling pathway 💬 26 genes, 64 drugs (DrugBank) and 99 diseases |
TNF [1] TNF 💬C-type lectin receptor signaling pathway
|
Infliximab Infliximab 💬C-type lectin receptor signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬33. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
AGTR1 [1] AGTR1 💬Calcium signaling pathway
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬34. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
CYSLTR1 [1] CYSLTR1 💬Calcium signaling pathway
|
Montelukast Montelukast 💬Calcium signaling pathway
| Montelukast | 006 [8] 6 , 13, 46, 61, 63, 85, 98, 228 💬35. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
HRH1 [1] HRH1 💬Calcium signaling pathway
|
Loratadine Loratadine 💬Calcium signaling pathway
| Loratadine | 013 [4] 13, 46, 89, 98 💬36. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
HRH2 [1] HRH2 💬Calcium signaling pathway
|
Famotidine Famotidine 💬Calcium signaling pathway
| Famotidine | 006 [6] 6 , 46, 61, 86, 98, 107 💬37. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Cellular senescence 💬 26 genes, 40 drugs (DrugBank) and 92 diseases |
MTOR [1] MTOR 💬Cellular senescence
|
Sirolimus Sirolimus 💬Cellular senescence
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬38. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
MTOR [1] MTOR 💬Central carbon metabolism in cancer
|
Sirolimus Sirolimus 💬Central carbon metabolism in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬39. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | cGMP-PKG signaling pathway 💬 46 genes, 119 drugs (DrugBank) and 118 diseases |
AGTR1 [1] AGTR1 💬cGMP-PKG signaling pathway
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬40. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Chagas disease 💬 28 genes, 44 drugs (DrugBank) and 77 diseases |
TNF [1] TNF 💬Chagas disease
|
Infliximab Infliximab 💬Chagas disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬41. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
MTOR [1] MTOR 💬Chemical carcinogenesis - receptor activation
|
Sirolimus Sirolimus 💬Chemical carcinogenesis - receptor activation
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬42. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
VDR [1] VDR 💬Chemical carcinogenesis - receptor activation
|
Cholecalciferol Cholecalciferol 💬Chemical carcinogenesis - receptor activation
| Cholecalciferol | 006 [24] 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬43. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Choline metabolism in cancer 💬 11 genes, 25 drugs (DrugBank) and 53 diseases |
MTOR [1] MTOR 💬Choline metabolism in cancer
|
Sirolimus Sirolimus 💬Choline metabolism in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬44. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Collecting duct acid secretion 💬 3 genes, 11 drugs (DrugBank) and 35 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Dexlansoprazole Dexlansoprazole 💬Collecting duct acid secretion
| Dexlansoprazole | 098 [1] 98 💬45. Collecting duct acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Collecting duct acid secretion 💬 3 genes, 11 drugs (DrugBank) and 35 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Esomeprazole Esomeprazole 💬Collecting duct acid secretion
| Esomeprazole | 013 [8] 13, 46, 86, 98, 107, 113, 298, 299 💬46. Collecting duct acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Collecting duct acid secretion 💬 3 genes, 11 drugs (DrugBank) and 35 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Collecting duct acid secretion
| Lansoprazole | 063 [7] 63, 71, 85, 98, 166, 222, 299 💬47. Collecting duct acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Collecting duct acid secretion 💬 3 genes, 11 drugs (DrugBank) and 35 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Vonoprazan Vonoprazan 💬Collecting duct acid secretion
| Vonoprazan | 063 [2] 63, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Colorectal cancer 💬 14 genes, 23 drugs (DrugBank) and 49 diseases |
MTOR [1] MTOR 💬Colorectal cancer
|
Sirolimus Sirolimus 💬Colorectal cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬49. Colorectal cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
AGTR1 [1] AGTR1 💬Coronavirus disease - COVID-19
|
Losartan Losartan 💬Coronavirus disease - COVID-19
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬50. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬Coronavirus disease - COVID-19
|
Infliximab Infliximab 💬Coronavirus disease - COVID-19
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬51. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Cortisol synthesis and secretion 💬 15 genes, 33 drugs (DrugBank) and 61 diseases |
AGTR1 [1] AGTR1 💬Cortisol synthesis and secretion
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬52. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Cushing syndrome 💬 24 genes, 50 drugs (DrugBank) and 66 diseases |
AGTR1 [1] AGTR1 💬Cushing syndrome
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬53. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL4R [1] IL4R 💬Cytokine-cytokine receptor interaction
|
Dupilumab Dupilumab 💬Cytokine-cytokine receptor interaction
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬54. Cytokine-cytokine receptor interaction |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5 [1] IL5 💬Cytokine-cytokine receptor interaction
|
Mepolizumab Mepolizumab 💬Cytokine-cytokine receptor interaction
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬55. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5 [1] IL5 💬Cytokine-cytokine receptor interaction
|
Reslizumab Reslizumab 💬Cytokine-cytokine receptor interaction
| Reslizumab | 044 [2] 44, 98 💬56. Cytokine-cytokine receptor interaction |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5RA [1] IL5RA 💬Cytokine-cytokine receptor interaction
|
Benralizumab Benralizumab 💬Cytokine-cytokine receptor interaction
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬57. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
TNF [1] TNF 💬Cytokine-cytokine receptor interaction
|
Infliximab Infliximab 💬Cytokine-cytokine receptor interaction
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬58. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
TSLP [1] TSLP 💬Cytokine-cytokine receptor interaction
|
Tezepelumab Tezepelumab 💬Cytokine-cytokine receptor interaction
| Tezepelumab | 098 [1] 98 💬59. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Diabetic cardiomyopathy 💬 26 genes, 42 drugs (DrugBank) and 73 diseases |
AGTR1 [1] AGTR1 💬Diabetic cardiomyopathy
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬60. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Diabetic cardiomyopathy 💬 26 genes, 42 drugs (DrugBank) and 73 diseases |
MTOR [1] MTOR 💬Diabetic cardiomyopathy
|
Sirolimus Sirolimus 💬Diabetic cardiomyopathy
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬61. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
TNF [1] TNF 💬Dilated cardiomyopathy
|
Infliximab Infliximab 💬Dilated cardiomyopathy
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬62. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
MTOR [1] MTOR 💬EGFR tyrosine kinase inhibitor resistance
|
Sirolimus Sirolimus 💬EGFR tyrosine kinase inhibitor resistance
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬63. EGFR tyrosine kinase inhibitor resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Endocrine and other factor-regulated calcium reabsorption 💬 8 genes, 27 drugs (DrugBank) and 55 diseases |
VDR [1] VDR 💬Endocrine and other factor-regulated calcium reabsorption
|
Cholecalciferol Cholecalciferol 💬Endocrine and other factor-regulated calcium reabsorption
| Cholecalciferol | 006 [24] 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬64. Endocrine and other factor-regulated calcium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Endocrine resistance 💬 20 genes, 43 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Endocrine resistance
|
Sirolimus Sirolimus 💬Endocrine resistance
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬65. Endocrine resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
TNF [1] TNF 💬Epstein-Barr virus infection
|
Infliximab Infliximab 💬Epstein-Barr virus infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬66. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | ErbB signaling pathway 💬 14 genes, 26 drugs (DrugBank) and 53 diseases |
MTOR [1] MTOR 💬ErbB signaling pathway
|
Sirolimus Sirolimus 💬ErbB signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬67. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
FCER1A [1] FCER1A 💬Fc epsilon RI signaling pathway
|
Omalizumab Omalizumab 💬Fc epsilon RI signaling pathway
| Omalizumab | 046 [7] 46, 53, 65, 98, 162, 226, 299 💬68. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL5 [1] IL5 💬Fc epsilon RI signaling pathway
|
Mepolizumab Mepolizumab 💬Fc epsilon RI signaling pathway
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬69. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL5 [1] IL5 💬Fc epsilon RI signaling pathway
|
Reslizumab Reslizumab 💬Fc epsilon RI signaling pathway
| Reslizumab | 044 [2] 44, 98 💬70. Fc epsilon RI signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
TNF [1] TNF 💬Fc epsilon RI signaling pathway
|
Infliximab Infliximab 💬Fc epsilon RI signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬71. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬Fluid shear stress and atherosclerosis
|
Infliximab Infliximab 💬Fluid shear stress and atherosclerosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬72. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | FoxO signaling pathway 💬 24 genes, 40 drugs (DrugBank) and 54 diseases |
S1PR1 [2] S1PR1, S1PR4 💬
|
Etrasimod Etrasimod 💬FoxO signaling pathway
| Etrasimod | 096 [3] 96, 97, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | GABAergic synapse 💬 29 genes, 38 drugs (DrugBank) and 55 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬GABAergic synapse
|
Propofol Propofol 💬GABAergic synapse
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬74. GABAergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Dexlansoprazole Dexlansoprazole 💬Gastric acid secretion
| Dexlansoprazole | 098 [1] 98 💬75. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Esomeprazole Esomeprazole 💬Gastric acid secretion
| Esomeprazole | 013 [8] 13, 46, 86, 98, 107, 113, 298, 299 💬76. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Gastric acid secretion
| Lansoprazole | 063 [7] 63, 71, 85, 98, 166, 222, 299 💬77. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Vonoprazan Vonoprazan 💬Gastric acid secretion
| Vonoprazan | 063 [2] 63, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
HRH2 [1] HRH2 💬Gastric acid secretion
|
Famotidine Famotidine 💬Gastric acid secretion
| Famotidine | 006 [6] 6 , 46, 61, 86, 98, 107 💬79. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Gastric cancer 💬 21 genes, 34 drugs (DrugBank) and 57 diseases |
MTOR [1] MTOR 💬Gastric cancer
|
Sirolimus Sirolimus 💬Gastric cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬80. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Glioma 💬 15 genes, 30 drugs (DrugBank) and 57 diseases |
MTOR [1] MTOR 💬Glioma
|
Sirolimus Sirolimus 💬Glioma
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬81. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Graft-versus-host disease 💬 7 genes, 22 drugs (DrugBank) and 60 diseases |
TNF [1] TNF 💬Graft-versus-host disease
|
Infliximab Infliximab 💬Graft-versus-host disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬82. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Growth hormone synthesis, secretion and action 💬 24 genes, 41 drugs (DrugBank) and 76 diseases |
MTOR [1] MTOR 💬Growth hormone synthesis, secretion and action
|
Sirolimus Sirolimus 💬Growth hormone synthesis, secretion and action
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬83. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL4R [1] IL4R 💬Hematopoietic cell lineage
|
Dupilumab Dupilumab 💬Hematopoietic cell lineage
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬84. Hematopoietic cell lineage |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5 [1] IL5 💬Hematopoietic cell lineage
|
Mepolizumab Mepolizumab 💬Hematopoietic cell lineage
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬85. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5 [1] IL5 💬Hematopoietic cell lineage
|
Reslizumab Reslizumab 💬Hematopoietic cell lineage
| Reslizumab | 044 [2] 44, 98 💬86. Hematopoietic cell lineage |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5RA [1] IL5RA 💬Hematopoietic cell lineage
|
Benralizumab Benralizumab 💬Hematopoietic cell lineage
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬87. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
TNF [1] TNF 💬Hematopoietic cell lineage
|
Infliximab Infliximab 💬Hematopoietic cell lineage
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬88. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
TNF [1] TNF 💬Hepatitis B
|
Infliximab Infliximab 💬Hepatitis B
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬89. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
TNF [1] TNF 💬Hepatitis C
|
Infliximab Infliximab 💬Hepatitis C
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬90. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | Hepatocellular carcinoma 💬 21 genes, 31 drugs (DrugBank) and 57 diseases |
MTOR [1] MTOR 💬Hepatocellular carcinoma
|
Sirolimus Sirolimus 💬Hepatocellular carcinoma
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬91. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
MTOR [1] MTOR 💬Herpes simplex virus 1 infection
|
Sirolimus Sirolimus 💬Herpes simplex virus 1 infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬92. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
TNF [1] TNF 💬Herpes simplex virus 1 infection
|
Infliximab Infliximab 💬Herpes simplex virus 1 infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬93. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases |
MTOR [1] MTOR 💬HIF-1 signaling pathway
|
Sirolimus Sirolimus 💬HIF-1 signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬94. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
MTOR [1] MTOR 💬Human cytomegalovirus infection
|
Sirolimus Sirolimus 💬Human cytomegalovirus infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬95. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
TNF [1] TNF 💬Human cytomegalovirus infection
|
Infliximab Infliximab 💬Human cytomegalovirus infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬96. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | Human immunodeficiency virus 1 infection 💬 41 genes, 43 drugs (DrugBank) and 89 diseases |
MTOR [1] MTOR 💬Human immunodeficiency virus 1 infection
|
Sirolimus Sirolimus 💬Human immunodeficiency virus 1 infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬97. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Human immunodeficiency virus 1 infection 💬 41 genes, 43 drugs (DrugBank) and 89 diseases |
TNF [1] TNF 💬Human immunodeficiency virus 1 infection
|
Infliximab Infliximab 💬Human immunodeficiency virus 1 infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬98. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
MTOR [1] MTOR 💬Human papillomavirus infection
|
Sirolimus Sirolimus 💬Human papillomavirus infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬99. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
TNF [1] TNF 💬Human papillomavirus infection
|
Infliximab Infliximab 💬Human papillomavirus infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬100. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬Human T-cell leukemia virus 1 infection
|
Infliximab Infliximab 💬Human T-cell leukemia virus 1 infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬101. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | Huntington disease 💬 24 genes, 33 drugs (DrugBank) and 82 diseases |
MTOR [1] MTOR 💬Huntington disease
|
Sirolimus Sirolimus 💬Huntington disease
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬102. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬Hypertrophic cardiomyopathy
|
Infliximab Infliximab 💬Hypertrophic cardiomyopathy
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬103. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
104 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL5 [1] IL5 💬IL-17 signaling pathway
|
Mepolizumab Mepolizumab 💬IL-17 signaling pathway
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬104. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
105 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL5 [1] IL5 💬IL-17 signaling pathway
|
Reslizumab Reslizumab 💬IL-17 signaling pathway
| Reslizumab | 044 [2] 44, 98 💬105. IL-17 signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
106 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
TNF [1] TNF 💬IL-17 signaling pathway
|
Infliximab Infliximab 💬IL-17 signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬106. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
107 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL4R [1] IL4R 💬Inflammatory bowel disease
|
Dupilumab Dupilumab 💬Inflammatory bowel disease
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬107. Inflammatory bowel disease |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
108 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL5 [1] IL5 💬Inflammatory bowel disease
|
Mepolizumab Mepolizumab 💬Inflammatory bowel disease
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬108. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL5 [1] IL5 💬Inflammatory bowel disease
|
Reslizumab Reslizumab 💬Inflammatory bowel disease
| Reslizumab | 044 [2] 44, 98 💬109. Inflammatory bowel disease |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Inflammatory bowel disease
|
Infliximab Infliximab 💬Inflammatory bowel disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬110. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
111 | Inflammatory mediator regulation of TRP channels 💬 23 genes, 43 drugs (DrugBank) and 59 diseases |
HRH1 [1] HRH1 💬Inflammatory mediator regulation of TRP channels
|
Loratadine Loratadine 💬Inflammatory mediator regulation of TRP channels
| Loratadine | 013 [4] 13, 46, 89, 98 💬111. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
112 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
TNF [1] TNF 💬Influenza A
|
Infliximab Infliximab 💬Influenza A
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬112. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
113 | Insulin resistance 💬 18 genes, 33 drugs (DrugBank) and 95 diseases |
MTOR [1] MTOR 💬Insulin resistance
|
Sirolimus Sirolimus 💬Insulin resistance
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬113. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
114 | Insulin resistance 💬 18 genes, 33 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬Insulin resistance
|
Infliximab Infliximab 💬Insulin resistance
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬114. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
115 | Insulin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
MTOR [1] MTOR 💬Insulin signaling pathway
|
Sirolimus Sirolimus 💬Insulin signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬115. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
IL5 [1] IL5 💬Intestinal immune network for IgA production
|
Mepolizumab Mepolizumab 💬Intestinal immune network for IgA production
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬116. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
117 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
IL5 [1] IL5 💬Intestinal immune network for IgA production
|
Reslizumab Reslizumab 💬Intestinal immune network for IgA production
| Reslizumab | 044 [2] 44, 98 💬117. Intestinal immune network for IgA production |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
118 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL4R [1] IL4R 💬JAK-STAT signaling pathway
|
Dupilumab Dupilumab 💬JAK-STAT signaling pathway
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬118. JAK-STAT signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
119 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5 [1] IL5 💬JAK-STAT signaling pathway
|
Mepolizumab Mepolizumab 💬JAK-STAT signaling pathway
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬119. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5 [1] IL5 💬JAK-STAT signaling pathway
|
Reslizumab Reslizumab 💬JAK-STAT signaling pathway
| Reslizumab | 044 [2] 44, 98 💬120. JAK-STAT signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
121 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5RA [1] IL5RA 💬JAK-STAT signaling pathway
|
Benralizumab Benralizumab 💬JAK-STAT signaling pathway
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬121. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
122 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
MTOR [1] MTOR 💬JAK-STAT signaling pathway
|
Sirolimus Sirolimus 💬JAK-STAT signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬122. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
123 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
TSLP [1] TSLP 💬JAK-STAT signaling pathway
|
Tezepelumab Tezepelumab 💬JAK-STAT signaling pathway
| Tezepelumab | 098 [1] 98 💬123. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
124 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
MTOR [1] MTOR 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirolimus Sirolimus 💬Kaposi sarcoma-associated herpesvirus infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬124. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
125 | Legionellosis 💬 9 genes, 22 drugs (DrugBank) and 61 diseases |
TNF [1] TNF 💬Legionellosis
|
Infliximab Infliximab 💬Legionellosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬125. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
126 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases |
TNF [1] TNF 💬Leishmaniasis
|
Infliximab Infliximab 💬Leishmaniasis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬126. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
127 | Lipid and atherosclerosis 💬 46 genes, 56 drugs (DrugBank) and 93 diseases |
TNF [1] TNF 💬Lipid and atherosclerosis
|
Infliximab Infliximab 💬Lipid and atherosclerosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬127. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
128 | Longevity regulating pathway 💬 11 genes, 20 drugs (DrugBank) and 68 diseases |
MTOR [1] MTOR 💬Longevity regulating pathway
|
Sirolimus Sirolimus 💬Longevity regulating pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬128. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
129 | Longevity regulating pathway - multiple species 💬 11 genes, 15 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Longevity regulating pathway - multiple species
|
Sirolimus Sirolimus 💬Longevity regulating pathway - multiple species
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬129. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
130 | Malaria 💬 15 genes, 28 drugs (DrugBank) and 61 diseases |
TNF [1] TNF 💬Malaria
|
Infliximab Infliximab 💬Malaria
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬130. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
131 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
TNF [1] TNF 💬MAPK signaling pathway
|
Infliximab Infliximab 💬MAPK signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬131. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
132 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Dexlansoprazole Dexlansoprazole 💬Metabolic pathways
| Dexlansoprazole | 098 [1] 98 💬132. Metabolic pathways
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
133 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Esomeprazole Esomeprazole 💬Metabolic pathways
| Esomeprazole | 013 [8] 13, 46, 86, 98, 107, 113, 298, 299 💬133. Metabolic pathways
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
134 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Metabolic pathways
| Lansoprazole | 063 [7] 63, 71, 85, 98, 166, 222, 299 💬134. Metabolic pathways
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
135 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Vonoprazan Vonoprazan 💬Metabolic pathways
| Vonoprazan | 063 [2] 63, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
136 | MicroRNAs in cancer 💬 31 genes, 65 drugs (DrugBank) and 85 diseases |
MTOR [1] MTOR 💬MicroRNAs in cancer
|
Sirolimus Sirolimus 💬MicroRNAs in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬136. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
137 | Mineral absorption 💬 8 genes, 13 drugs (DrugBank) and 41 diseases |
VDR [1] VDR 💬Mineral absorption
|
Cholecalciferol Cholecalciferol 💬Mineral absorption
| Cholecalciferol | 006 [24] 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬137. Mineral absorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
138 | Morphine addiction 💬 41 genes, 65 drugs (DrugBank) and 73 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬Morphine addiction
|
Propofol Propofol 💬Morphine addiction
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬138. Morphine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
139 | mTOR signaling pathway 💬 14 genes, 32 drugs (DrugBank) and 91 diseases |
MTOR [1] MTOR 💬mTOR signaling pathway
|
Sirolimus Sirolimus 💬mTOR signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬139. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
140 | mTOR signaling pathway 💬 14 genes, 32 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬mTOR signaling pathway
|
Infliximab Infliximab 💬mTOR signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬140. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
141 | Natural killer cell mediated cytotoxicity 💬 37 genes, 42 drugs (DrugBank) and 80 diseases |
TNF [1] TNF 💬Natural killer cell mediated cytotoxicity
|
Infliximab Infliximab 💬Natural killer cell mediated cytotoxicity
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬141. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
142 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Necroptosis
|
Infliximab Infliximab 💬Necroptosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬142. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
143 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
AGTR1 [1] AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬143. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
144 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
CYSLTR1 [1] CYSLTR1 💬Neuroactive ligand-receptor interaction
|
Montelukast Montelukast 💬Neuroactive ligand-receptor interaction
| Montelukast | 006 [8] 6 , 13, 46, 61, 63, 85, 98, 228 💬144. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
145 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬Neuroactive ligand-receptor interaction
|
Propofol Propofol 💬Neuroactive ligand-receptor interaction
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬145. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
146 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
HRH1 [1] HRH1 💬Neuroactive ligand-receptor interaction
|
Loratadine Loratadine 💬Neuroactive ligand-receptor interaction
| Loratadine | 013 [4] 13, 46, 89, 98 💬146. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
147 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
HRH2 [1] HRH2 💬Neuroactive ligand-receptor interaction
|
Famotidine Famotidine 💬Neuroactive ligand-receptor interaction
| Famotidine | 006 [6] 6 , 46, 61, 86, 98, 107 💬147. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
148 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Beclomethasone dipropionate Beclomethasone dipropionate 💬Neuroactive ligand-receptor interaction
| Beclomethasone dipropionate | 085 [3] 85, 97, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
149 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Budesonide Budesonide 💬Neuroactive ligand-receptor interaction
| Budesonide | 066 [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬149. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
150 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Fluticasone Fluticasone 💬Neuroactive ligand-receptor interaction
| Fluticasone | 098 [3] 98, 228, 299 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
151 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Fluticasone propionate Fluticasone propionate 💬Neuroactive ligand-receptor interaction
| Fluticasone propionate | 098 [2] 98, 228 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
152 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Mometasone Mometasone 💬Neuroactive ligand-receptor interaction
| Mometasone | 098 [2] 98, 162 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
153 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
NR3C1 [1] NR3C1 💬Neuroactive ligand-receptor interaction
|
Mometasone furoate Mometasone furoate 💬Neuroactive ligand-receptor interaction
| Mometasone furoate | 098 [2] 98, 162 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
154 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
|
Etrasimod Etrasimod 💬Neuroactive ligand-receptor interaction
| Etrasimod | 096 [3] 96, 97, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
155 | Neutrophil extracellular trap formation 💬 35 genes, 36 drugs (DrugBank) and 61 diseases |
MTOR [1] MTOR 💬Neutrophil extracellular trap formation
|
Sirolimus Sirolimus 💬Neutrophil extracellular trap formation
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬155. Neutrophil extracellular trap formation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
156 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases |
TNF [1] TNF 💬NF-kappa B signaling pathway
|
Infliximab Infliximab 💬NF-kappa B signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬156. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
157 | Nicotine addiction 💬 30 genes, 30 drugs (DrugBank) and 44 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬Nicotine addiction
|
Propofol Propofol 💬Nicotine addiction
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬157. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
158 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
TNF [1] TNF 💬NOD-like receptor signaling pathway
|
Infliximab Infliximab 💬NOD-like receptor signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬158. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
159 | Non-alcoholic fatty liver disease 💬 23 genes, 47 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬Non-alcoholic fatty liver disease
|
Infliximab Infliximab 💬Non-alcoholic fatty liver disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬159. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
160 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
TNF [1] TNF 💬Osteoclast differentiation
|
Infliximab Infliximab 💬Osteoclast differentiation
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬160. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
161 | Oxidative phosphorylation 💬 2 genes, 7 drugs (DrugBank) and 25 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Dexlansoprazole Dexlansoprazole 💬Oxidative phosphorylation
| Dexlansoprazole | 098 [1] 98 💬161. Oxidative phosphorylation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
162 | Oxidative phosphorylation 💬 2 genes, 7 drugs (DrugBank) and 25 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Esomeprazole Esomeprazole 💬Oxidative phosphorylation
| Esomeprazole | 013 [8] 13, 46, 86, 98, 107, 113, 298, 299 💬162. Oxidative phosphorylation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
163 | Oxidative phosphorylation 💬 2 genes, 7 drugs (DrugBank) and 25 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬Oxidative phosphorylation
| Lansoprazole | 063 [7] 63, 71, 85, 98, 166, 222, 299 💬163. Oxidative phosphorylation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
164 | Oxidative phosphorylation 💬 2 genes, 7 drugs (DrugBank) and 25 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Vonoprazan Vonoprazan 💬Oxidative phosphorylation
| Vonoprazan | 063 [2] 63, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
165 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
MTOR [1] MTOR 💬Pancreatic cancer
|
Sirolimus Sirolimus 💬Pancreatic cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬165. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
166 | Parathyroid hormone synthesis, secretion and action 💬 21 genes, 48 drugs (DrugBank) and 65 diseases |
VDR [1] VDR 💬Parathyroid hormone synthesis, secretion and action
|
Cholecalciferol Cholecalciferol 💬Parathyroid hormone synthesis, secretion and action
| Cholecalciferol | 006 [24] 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬166. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
167 | Pathogenic Escherichia coli infection 💬 26 genes, 39 drugs (DrugBank) and 74 diseases |
TNF [1] TNF 💬Pathogenic Escherichia coli infection
|
Infliximab Infliximab 💬Pathogenic Escherichia coli infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬167. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
168 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
AGTR1 [1] AGTR1 💬Pathways in cancer
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬168. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
169 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL4R [1] IL4R 💬Pathways in cancer
|
Dupilumab Dupilumab 💬Pathways in cancer
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
170 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 [1] IL5 💬Pathways in cancer
|
Mepolizumab Mepolizumab 💬Pathways in cancer
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬170. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
171 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 [1] IL5 💬Pathways in cancer
|
Reslizumab Reslizumab 💬Pathways in cancer
| Reslizumab | 044 [2] 44, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
172 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5RA [1] IL5RA 💬Pathways in cancer
|
Benralizumab Benralizumab 💬Pathways in cancer
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬172. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
173 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MTOR [1] MTOR 💬Pathways in cancer
|
Sirolimus Sirolimus 💬Pathways in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬173. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
174 | Pathways of neurodegeneration - multiple diseases 💬 59 genes, 120 drugs (DrugBank) and 125 diseases |
MTOR [1] MTOR 💬Pathways of neurodegeneration - multiple diseases
|
Sirolimus Sirolimus 💬Pathways of neurodegeneration - multiple diseases
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬174. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
175 | Pathways of neurodegeneration - multiple diseases 💬 59 genes, 120 drugs (DrugBank) and 125 diseases |
TNF [1] TNF 💬Pathways of neurodegeneration - multiple diseases
|
Infliximab Infliximab 💬Pathways of neurodegeneration - multiple diseases
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬175. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
176 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
MTOR [1] MTOR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Sirolimus Sirolimus 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬176. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
177 | Pertussis 💬 18 genes, 38 drugs (DrugBank) and 66 diseases |
TNF [1] TNF 💬Pertussis
|
Infliximab Infliximab 💬Pertussis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬177. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
178 | Phospholipase D signaling pathway 💬 23 genes, 51 drugs (DrugBank) and 76 diseases |
AGTR1 [1] AGTR1 💬Phospholipase D signaling pathway
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬178. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
179 | Phospholipase D signaling pathway 💬 23 genes, 51 drugs (DrugBank) and 76 diseases |
FCER1A [1] FCER1A 💬Phospholipase D signaling pathway
|
Omalizumab Omalizumab 💬Phospholipase D signaling pathway
| Omalizumab | 046 [7] 46, 53, 65, 98, 162, 226, 299 💬179. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
180 | Phospholipase D signaling pathway 💬 23 genes, 51 drugs (DrugBank) and 76 diseases |
MTOR [1] MTOR 💬Phospholipase D signaling pathway
|
Sirolimus Sirolimus 💬Phospholipase D signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬180. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
181 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
IL4R [1] IL4R 💬PI3K-Akt signaling pathway
|
Dupilumab Dupilumab 💬PI3K-Akt signaling pathway
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬181. PI3K-Akt signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
182 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
MTOR [1] MTOR 💬PI3K-Akt signaling pathway
|
Sirolimus Sirolimus 💬PI3K-Akt signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬182. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
183 | Prion disease 💬 41 genes, 66 drugs (DrugBank) and 107 diseases |
TNF [1] TNF 💬Prion disease
|
Infliximab Infliximab 💬Prion disease
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬183. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
184 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases |
MTOR [1] MTOR 💬Prostate cancer
|
Sirolimus Sirolimus 💬Prostate cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬184. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
185 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases |
MTOR [1] MTOR 💬Proteoglycans in cancer
|
Sirolimus Sirolimus 💬Proteoglycans in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬185. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
186 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases |
TNF [1] TNF 💬Proteoglycans in cancer
|
Infliximab Infliximab 💬Proteoglycans in cancer
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬186. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
187 | Renin secretion 💬 28 genes, 82 drugs (DrugBank) and 107 diseases |
AGTR1 [1] AGTR1 💬Renin secretion
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬187. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
188 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 31 diseases |
AGTR1 [1] AGTR1 💬Renin-angiotensin system
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬188. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
189 | Retrograde endocannabinoid signaling 💬 34 genes, 62 drugs (DrugBank) and 67 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬Retrograde endocannabinoid signaling
|
Propofol Propofol 💬Retrograde endocannabinoid signaling
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬189. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
190 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
TNF [1] TNF 💬Rheumatoid arthritis
|
Infliximab Infliximab 💬Rheumatoid arthritis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬190. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
191 | RIG-I-like receptor signaling pathway 💬 22 genes, 18 drugs (DrugBank) and 55 diseases |
TNF [1] TNF 💬RIG-I-like receptor signaling pathway
|
Infliximab Infliximab 💬RIG-I-like receptor signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬191. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
192 | Salmonella infection 💬 27 genes, 40 drugs (DrugBank) and 66 diseases |
TNF [1] TNF 💬Salmonella infection
|
Infliximab Infliximab 💬Salmonella infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬192. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
193 | Serotonergic synapse 💬 38 genes, 112 drugs (DrugBank) and 79 diseases |
GABRB1 [3] GABRB1, GABRB2, GABRB3 💬
|
Propofol Propofol 💬Serotonergic synapse
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬193. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
194 | Serotonergic synapse 💬 38 genes, 112 drugs (DrugBank) and 79 diseases |
SLC6A4 [1] SLC6A4 💬Serotonergic synapse
|
Citalopram Citalopram 💬Serotonergic synapse
| Citalopram | 006 [7] 6 , 8 , 13, 18, 46, 98, 127 💬194. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
195 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases |
MTOR [1] MTOR 💬Shigellosis
|
Sirolimus Sirolimus 💬Shigellosis
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬195. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
196 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases |
TNF [1] TNF 💬Shigellosis
|
Infliximab Infliximab 💬Shigellosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬196. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
197 | Sphingolipid signaling pathway 💬 30 genes, 52 drugs (DrugBank) and 73 diseases |
FCER1A [1] FCER1A 💬Sphingolipid signaling pathway
|
Omalizumab Omalizumab 💬Sphingolipid signaling pathway
| Omalizumab | 046 [7] 46, 53, 65, 98, 162, 226, 299 💬197. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
198 | Sphingolipid signaling pathway 💬 30 genes, 52 drugs (DrugBank) and 73 diseases |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
|
Etrasimod Etrasimod 💬Sphingolipid signaling pathway
| Etrasimod | 096 [3] 96, 97, 98 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
199 | Sphingolipid signaling pathway 💬 30 genes, 52 drugs (DrugBank) and 73 diseases |
TNF [1] TNF 💬Sphingolipid signaling pathway
|
Infliximab Infliximab 💬Sphingolipid signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬199. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
200 | Spinocerebellar ataxia 💬 17 genes, 25 drugs (DrugBank) and 70 diseases |
MTOR [1] MTOR 💬Spinocerebellar ataxia
|
Sirolimus Sirolimus 💬Spinocerebellar ataxia
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬200. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
201 | Synaptic vesicle cycle 💬 7 genes, 30 drugs (DrugBank) and 40 diseases |
SLC6A4 [1] SLC6A4 💬Synaptic vesicle cycle
|
Citalopram Citalopram 💬Synaptic vesicle cycle
| Citalopram | 006 [7] 6 , 8 , 13, 18, 46, 98, 127 💬201. Synaptic vesicle cycle
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
202 | Systemic lupus erythematosus 💬 14 genes, 38 drugs (DrugBank) and 78 diseases |
TNF [1] TNF 💬Systemic lupus erythematosus
|
Infliximab Infliximab 💬Systemic lupus erythematosus
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬202. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
203 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
IL5 [1] IL5 💬T cell receptor signaling pathway
|
Mepolizumab Mepolizumab 💬T cell receptor signaling pathway
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬203. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
204 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
IL5 [1] IL5 💬T cell receptor signaling pathway
|
Reslizumab Reslizumab 💬T cell receptor signaling pathway
| Reslizumab | 044 [2] 44, 98 💬204. T cell receptor signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
205 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
TNF [1] TNF 💬T cell receptor signaling pathway
|
Infliximab Infliximab 💬T cell receptor signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬205. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
206 | Taste transduction 💬 30 genes, 81 drugs (DrugBank) and 65 diseases |
GABRA1 [6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬Taste transduction
|
Propofol Propofol 💬Taste transduction
| Propofol | 006 [9] 6 , 21, 22, 34, 46, 70, 75, 98, 296 💬206. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
207 | TGF-beta signaling pathway 💬 10 genes, 20 drugs (DrugBank) and 55 diseases |
TNF [1] TNF 💬TGF-beta signaling pathway
|
Infliximab Infliximab 💬TGF-beta signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬207. TGF-beta signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
208 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL4R [1] IL4R 💬Th1 and Th2 cell differentiation
|
Dupilumab Dupilumab 💬Th1 and Th2 cell differentiation
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬208. Th1 and Th2 cell differentiation |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
209 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL5 [1] IL5 💬Th1 and Th2 cell differentiation
|
Mepolizumab Mepolizumab 💬Th1 and Th2 cell differentiation
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬209. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
210 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL5 [1] IL5 💬Th1 and Th2 cell differentiation
|
Reslizumab Reslizumab 💬Th1 and Th2 cell differentiation
| Reslizumab | 044 [2] 44, 98 💬210. Th1 and Th2 cell differentiation |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
211 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
IL4R [1] IL4R 💬Th17 cell differentiation
|
Dupilumab Dupilumab 💬Th17 cell differentiation
| Dupilumab | 051 [5] 51, 97, 98, 160, 162 💬211. Th17 cell differentiation |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
212 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
MTOR [1] MTOR 💬Th17 cell differentiation
|
Sirolimus Sirolimus 💬Th17 cell differentiation
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬212. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
213 | Thermogenesis 💬 17 genes, 29 drugs (DrugBank) and 82 diseases |
MTOR [1] MTOR 💬Thermogenesis
|
Sirolimus Sirolimus 💬Thermogenesis
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬213. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
214 | Thyroid hormone signaling pathway 💬 24 genes, 41 drugs (DrugBank) and 67 diseases |
MTOR [1] MTOR 💬Thyroid hormone signaling pathway
|
Sirolimus Sirolimus 💬Thyroid hormone signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬214. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
215 | TNF signaling pathway 💬 18 genes, 56 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬TNF signaling pathway
|
Infliximab Infliximab 💬TNF signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬215. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
216 | Toll-like receptor signaling pathway 💬 36 genes, 46 drugs (DrugBank) and 65 diseases |
TNF [1] TNF 💬Toll-like receptor signaling pathway
|
Infliximab Infliximab 💬Toll-like receptor signaling pathway
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬216. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
217 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
TNF [1] TNF 💬Toxoplasmosis
|
Infliximab Infliximab 💬Toxoplasmosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬217. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
218 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬Tuberculosis
|
Infliximab Infliximab 💬Tuberculosis
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬218. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
219 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases |
VDR [1] VDR 💬Tuberculosis
|
Cholecalciferol Cholecalciferol 💬Tuberculosis
| Cholecalciferol | 006 [24] 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬219. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
220 | Type I diabetes mellitus 💬 11 genes, 22 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Type I diabetes mellitus
|
Infliximab Infliximab 💬Type I diabetes mellitus
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬220. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
221 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases |
MTOR [1] MTOR 💬Type II diabetes mellitus
|
Sirolimus Sirolimus 💬Type II diabetes mellitus
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬221. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
222 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬Type II diabetes mellitus
|
Infliximab Infliximab 💬Type II diabetes mellitus
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬222. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
223 | Vascular smooth muscle contraction 💬 31 genes, 77 drugs (DrugBank) and 68 diseases |
AGTR1 [1] AGTR1 💬Vascular smooth muscle contraction
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 [17] 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬223. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
224 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 29 drugs (DrugBank) and 60 diseases |
TNF [1] TNF 💬Viral protein interaction with cytokine and cytokine receptor
|
Infliximab Infliximab 💬Viral protein interaction with cytokine and cytokine receptor
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬224. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
225 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases |
TNF [1] TNF 💬Yersinia infection
|
Infliximab Infliximab 💬Yersinia infection
| Infliximab | 035 [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬225. Yersinia infection
|
Acute myeloid leukemia
17 genes, 30 drugs (DrugBank) and 62 diseases
Adipocytokine signaling pathway
16 genes, 31 drugs (DrugBank) and 95 diseases
Adrenergic signaling in cardiomyocytes
27 genes, 80 drugs (DrugBank) and 71 diseases
African trypanosomiasis
9 genes, 22 drugs (DrugBank) and 59 diseases
AGE-RAGE signaling pathway in diabetic complications
26 genes, 45 drugs (DrugBank) and 83 diseases
Alcoholic liver disease
39 genes, 46 drugs (DrugBank) and 87 diseases
Aldosterone synthesis and secretion
20 genes, 38 drugs (DrugBank) and 62 diseases
Allograft rejection
11 genes, 23 drugs (DrugBank) and 56 diseases
Alzheimer disease
55 genes, 116 drugs (DrugBank) and 122 diseases
Amoebiasis
19 genes, 29 drugs (DrugBank) and 63 diseases
AMPK signaling pathway
16 genes, 49 drugs (DrugBank) and 93 diseases
Amyotrophic lateral sclerosis
35 genes, 48 drugs (DrugBank) and 108 diseases
Antifolate resistance
8 genes, 21 drugs (DrugBank) and 66 diseases
Antigen processing and presentation
4 genes, 15 drugs (DrugBank) and 52 diseases
Apelin signaling pathway
12 genes, 30 drugs (DrugBank) and 72 diseases
Apoptosis
16 genes, 28 drugs (DrugBank) and 59 diseases
Asthma
8 genes, 22 drugs (DrugBank) and 55 diseases
Autoimmune thyroid disease
22 genes, 15 drugs (DrugBank) and 35 diseases
Autophagy - animal
13 genes, 18 drugs (DrugBank) and 62 diseases
Autophagy - other
1 gene, 3 drugs (DrugBank) and 41 diseases
Breast cancer
21 genes, 60 drugs (DrugBank) and 74 diseases
C-type lectin receptor signaling pathway
26 genes, 64 drugs (DrugBank) and 99 diseases
Calcium signaling pathway
79 genes, 187 drugs (DrugBank) and 134 diseases
Cellular senescence
26 genes, 40 drugs (DrugBank) and 92 diseases
Central carbon metabolism in cancer
18 genes, 29 drugs (DrugBank) and 56 diseases
cGMP-PKG signaling pathway
46 genes, 119 drugs (DrugBank) and 118 diseases
Chagas disease
28 genes, 44 drugs (DrugBank) and 77 diseases
Chemical carcinogenesis - receptor activation
39 genes, 126 drugs (DrugBank) and 116 diseases
Choline metabolism in cancer
11 genes, 25 drugs (DrugBank) and 53 diseases
Collecting duct acid secretion
3 genes, 11 drugs (DrugBank) and 35 diseases
Colorectal cancer
14 genes, 23 drugs (DrugBank) and 49 diseases
Coronavirus disease - COVID-19
51 genes, 94 drugs (DrugBank) and 91 diseases
Cortisol synthesis and secretion
15 genes, 33 drugs (DrugBank) and 61 diseases
Cushing syndrome
24 genes, 50 drugs (DrugBank) and 66 diseases
Cytokine-cytokine receptor interaction
81 genes, 114 drugs (DrugBank) and 92 diseases
Diabetic cardiomyopathy
26 genes, 42 drugs (DrugBank) and 73 diseases
Dilated cardiomyopathy
17 genes, 55 drugs (DrugBank) and 83 diseases
EGFR tyrosine kinase inhibitor resistance
26 genes, 56 drugs (DrugBank) and 83 diseases
Endocrine and other factor-regulated calcium reabsorption
8 genes, 27 drugs (DrugBank) and 55 diseases
Endocrine resistance
20 genes, 43 drugs (DrugBank) and 62 diseases
Epstein-Barr virus infection
44 genes, 62 drugs (DrugBank) and 66 diseases
ErbB signaling pathway
14 genes, 26 drugs (DrugBank) and 53 diseases
Fc epsilon RI signaling pathway
20 genes, 42 drugs (DrugBank) and 62 diseases
Fluid shear stress and atherosclerosis
29 genes, 48 drugs (DrugBank) and 86 diseases
FoxO signaling pathway
24 genes, 40 drugs (DrugBank) and 54 diseases
GABAergic synapse
29 genes, 38 drugs (DrugBank) and 55 diseases
Gastric acid secretion
14 genes, 43 drugs (DrugBank) and 52 diseases
Gastric cancer
21 genes, 34 drugs (DrugBank) and 57 diseases
Glioma
15 genes, 30 drugs (DrugBank) and 57 diseases
Graft-versus-host disease
7 genes, 22 drugs (DrugBank) and 60 diseases
Growth hormone synthesis, secretion and action
24 genes, 41 drugs (DrugBank) and 76 diseases
Hematopoietic cell lineage
32 genes, 70 drugs (DrugBank) and 90 diseases
Hepatitis B
41 genes, 54 drugs (DrugBank) and 73 diseases
Hepatitis C
34 genes, 59 drugs (DrugBank) and 72 diseases
Hepatocellular carcinoma
21 genes, 31 drugs (DrugBank) and 57 diseases
Herpes simplex virus 1 infection
43 genes, 65 drugs (DrugBank) and 94 diseases
HIF-1 signaling pathway
23 genes, 48 drugs (DrugBank) and 76 diseases
Human cytomegalovirus infection
56 genes, 104 drugs (DrugBank) and 120 diseases
Human immunodeficiency virus 1 infection
41 genes, 43 drugs (DrugBank) and 89 diseases
Human papillomavirus infection
40 genes, 91 drugs (DrugBank) and 105 diseases
Human T-cell leukemia virus 1 infection
37 genes, 59 drugs (DrugBank) and 84 diseases
Huntington disease
24 genes, 33 drugs (DrugBank) and 82 diseases
Hypertrophic cardiomyopathy
20 genes, 51 drugs (DrugBank) and 87 diseases
IL-17 signaling pathway
20 genes, 60 drugs (DrugBank) and 83 diseases
Inflammatory bowel disease
24 genes, 43 drugs (DrugBank) and 64 diseases
Inflammatory mediator regulation of TRP channels
23 genes, 43 drugs (DrugBank) and 59 diseases
Influenza A
45 genes, 63 drugs (DrugBank) and 85 diseases
Insulin resistance
18 genes, 33 drugs (DrugBank) and 95 diseases
Insulin signaling pathway
12 genes, 26 drugs (DrugBank) and 66 diseases
Intestinal immune network for IgA production
16 genes, 27 drugs (DrugBank) and 47 diseases
JAK-STAT signaling pathway
58 genes, 91 drugs (DrugBank) and 96 diseases
Kaposi sarcoma-associated herpesvirus infection
50 genes, 84 drugs (DrugBank) and 108 diseases
Legionellosis
9 genes, 22 drugs (DrugBank) and 61 diseases
Leishmaniasis
25 genes, 63 drugs (DrugBank) and 93 diseases
Lipid and atherosclerosis
46 genes, 56 drugs (DrugBank) and 93 diseases
Longevity regulating pathway
11 genes, 20 drugs (DrugBank) and 68 diseases
Longevity regulating pathway - multiple species
11 genes, 15 drugs (DrugBank) and 62 diseases
Malaria
15 genes, 28 drugs (DrugBank) and 61 diseases
MAPK signaling pathway
61 genes, 85 drugs (DrugBank) and 110 diseases
Metabolic pathways
111 genes, 155 drugs (DrugBank) and 137 diseases
MicroRNAs in cancer
31 genes, 65 drugs (DrugBank) and 85 diseases
Mineral absorption
8 genes, 13 drugs (DrugBank) and 41 diseases
Morphine addiction
41 genes, 65 drugs (DrugBank) and 73 diseases
mTOR signaling pathway
14 genes, 32 drugs (DrugBank) and 91 diseases
Natural killer cell mediated cytotoxicity
37 genes, 42 drugs (DrugBank) and 80 diseases
Necroptosis
28 genes, 39 drugs (DrugBank) and 68 diseases
Neuroactive ligand-receptor interaction
149 genes, 320 drugs (DrugBank) and 153 diseases
Neutrophil extracellular trap formation
35 genes, 36 drugs (DrugBank) and 61 diseases
NF-kappa B signaling pathway
20 genes, 67 drugs (DrugBank) and 87 diseases
Nicotine addiction
30 genes, 30 drugs (DrugBank) and 44 diseases
NOD-like receptor signaling pathway
30 genes, 42 drugs (DrugBank) and 65 diseases
Non-alcoholic fatty liver disease
23 genes, 47 drugs (DrugBank) and 86 diseases
Osteoclast differentiation
36 genes, 71 drugs (DrugBank) and 93 diseases
Oxidative phosphorylation
2 genes, 7 drugs (DrugBank) and 25 diseases
Pancreatic cancer
19 genes, 36 drugs (DrugBank) and 67 diseases
Parathyroid hormone synthesis, secretion and action
21 genes, 48 drugs (DrugBank) and 65 diseases
Pathogenic Escherichia coli infection
26 genes, 39 drugs (DrugBank) and 74 diseases
Pathways in cancer
104 genes, 194 drugs (DrugBank) and 133 diseases
Pathways of neurodegeneration - multiple diseases
59 genes, 120 drugs (DrugBank) and 125 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 51 drugs (DrugBank) and 92 diseases
Pertussis
18 genes, 38 drugs (DrugBank) and 66 diseases
Phospholipase D signaling pathway
23 genes, 51 drugs (DrugBank) and 76 diseases
PI3K-Akt signaling pathway
76 genes, 112 drugs (DrugBank) and 112 diseases
Prion disease
41 genes, 66 drugs (DrugBank) and 107 diseases
Prostate cancer
22 genes, 51 drugs (DrugBank) and 80 diseases
Proteoglycans in cancer
30 genes, 68 drugs (DrugBank) and 96 diseases
Renin secretion
28 genes, 82 drugs (DrugBank) and 107 diseases
Renin-angiotensin system
6 genes, 21 drugs (DrugBank) and 31 diseases
Retrograde endocannabinoid signaling
34 genes, 62 drugs (DrugBank) and 67 diseases
Rheumatoid arthritis
22 genes, 49 drugs (DrugBank) and 74 diseases
RIG-I-like receptor signaling pathway
22 genes, 18 drugs (DrugBank) and 55 diseases
Salmonella infection
27 genes, 40 drugs (DrugBank) and 66 diseases
Serotonergic synapse
38 genes, 112 drugs (DrugBank) and 79 diseases
Shigellosis
23 genes, 41 drugs (DrugBank) and 86 diseases
Sphingolipid signaling pathway
30 genes, 52 drugs (DrugBank) and 73 diseases
Spinocerebellar ataxia
17 genes, 25 drugs (DrugBank) and 70 diseases
Synaptic vesicle cycle
7 genes, 30 drugs (DrugBank) and 40 diseases
Systemic lupus erythematosus
14 genes, 38 drugs (DrugBank) and 78 diseases
T cell receptor signaling pathway
34 genes, 46 drugs (DrugBank) and 80 diseases
Taste transduction
30 genes, 81 drugs (DrugBank) and 65 diseases
TGF-beta signaling pathway
10 genes, 20 drugs (DrugBank) and 55 diseases
Th1 and Th2 cell differentiation
33 genes, 37 drugs (DrugBank) and 70 diseases
Th17 cell differentiation
43 genes, 66 drugs (DrugBank) and 97 diseases
Thermogenesis
17 genes, 29 drugs (DrugBank) and 82 diseases
Thyroid hormone signaling pathway
24 genes, 41 drugs (DrugBank) and 67 diseases
TNF signaling pathway
18 genes, 56 drugs (DrugBank) and 84 diseases
Toll-like receptor signaling pathway
36 genes, 46 drugs (DrugBank) and 65 diseases
Toxoplasmosis
25 genes, 39 drugs (DrugBank) and 64 diseases
Tuberculosis
49 genes, 65 drugs (DrugBank) and 91 diseases
Type I diabetes mellitus
11 genes, 22 drugs (DrugBank) and 68 diseases
Type II diabetes mellitus
14 genes, 39 drugs (DrugBank) and 91 diseases
Vascular smooth muscle contraction
31 genes, 77 drugs (DrugBank) and 68 diseases
Viral protein interaction with cytokine and cytokine receptor
17 genes, 29 drugs (DrugBank) and 60 diseases
Yersinia infection
22 genes, 39 drugs (DrugBank) and 69 diseases